Evaluation of Early Response to Neoadjuvant Chemotherapy with FDG PET/CT and MRI in Pediatric Patients with Bone Sarcoma

被引:0
|
作者
Caglar, M. [1 ]
Aydin, B. [1 ]
Ergen, B. [1 ]
Karabulut, E. [1 ]
Akyuz, C. [1 ]
机构
[1] Hacettepe Univ, Ankara, Turkey
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
OP495
引用
收藏
页码:S205 / S206
页数:2
相关论文
共 50 条
  • [31] Comparison of RECIST, EORTC criteria and PERCIST using MRI and PET/CT for evaluation of early response of neoadjuvant chemotherapy in patients with cervical carcinoma
    Sun, Yanqin
    Yu, Lijuan
    Nanding, Abiyasi
    Wang, Wenzhi
    Kuai, Zi-Xiang
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58
  • [32] FDG-PET/CT and MRI for Evaluation of Pathologic Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer: A Meta-Analysis of Diagnostic Accuracy Studies
    Sheikhbahaei, Sara
    Trahan, Tyler J.
    Xiao, Jennifer
    Taghipour, Mehdi
    Mena, Esther
    Connolly, Roisin M.
    Subramaniam, Rathan M.
    ONCOLOGIST, 2016, 21 (08): : 931 - 939
  • [33] Prognostic value of FDG-PET indices for the assessment of histological response to neoadjuvant chemotherapy and outcome in pediatric patients with Ewing sarcoma and osteosarcoma
    Bailly, Clement
    Leforestier, Rodolphe
    Campion, Loic
    Thebaud, Estelle
    Moreau, Anne
    Kraeber-Bodere, Francoise
    Carlier, Thomas
    Bodet-Milin, Caroline
    PLOS ONE, 2017, 12 (08):
  • [34] 18F-FDG PET/CT for early prediction of response to neoadjuvant chemotherapy in breast cancer
    Joan Duch
    David Fuster
    Montserrat Muñoz
    Pedro Luís Fernández
    Pilar Paredes
    Montserrat Fontanillas
    Flavia Guzmán
    Sebastià Rubí
    Francisco Juan Lomeña
    Francesca Pons
    European Journal of Nuclear Medicine and Molecular Imaging, 2009, 36 : 1551 - 1557
  • [35] 18F-FDG PET/CT for early prediction of response to neoadjuvant chemotherapy in breast cancer
    Duch, Joan
    Fuster, David
    Munoz, Montserrat
    Luis Fernandez, Pedro
    Paredes, Pilar
    Fontanillas, Montserrat
    Guzman, Flavia
    Rubi, Sebastia
    Juan Lomena, Francisco
    Pons, Francesca
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 (10) : 1551 - 1557
  • [36] Multi-parametric FDG PET/MRI as an early predictor of response to neoadjuvant chemotherapy in patients with epithelial ovarian cancer.
    Frey, Melissa Kristen
    Sawaged, Zacharia
    Franceschi, Ana M.
    Friedman, Kent P.
    Lutz, Kathleen
    Curtin, John Patrick
    Blank, Stephanie V.
    Pothuri, Bhavana
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [37] Multi-parametric FDG PET/MRI as an Early Predictor of Response to Neoadjuvant Chemotherapy in Patients wit Epithelial Ovarian Cancer
    Franceschi, Ana
    Pothuri, Bhavana
    Frey, Melissa
    Chandarana, Hersh
    Jackson, Kimberly
    Friedman, Kent
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [38] Utility of FDG-PET/CT in the Evaluation of the Response of Locally Advanced Breast Cancer to Neoadjuvant Chemotherapy
    Ogino, Kei
    Nakajima, Masanobu
    Kakuta, Miyako
    Hayashi, Mitsuhiro
    Yamaguchi, Satoru
    Tsuchioka, Takashi
    Kubota, Keiichi
    Sakamoto, Setsu
    Kato, Hiroyuki
    INTERNATIONAL SURGERY, 2014, 99 (04) : 309 - 318
  • [39] Early evaluation of neoadjuvant chemotherapy response using FDG-PET/CT predicts survival prognosis in patients with head and neck squamous cell carcinoma
    Masahiro Kikuchi
    Yuji Nakamoto
    Shogo Shinohara
    Keizo Fujiwara
    Hiroshi Yamazaki
    Yuji Kanazawa
    Risa Kurihara
    Ippei Kishimoto
    Hiroyuki Harada
    Yasushi Naito
    International Journal of Clinical Oncology, 2013, 18 : 402 - 410
  • [40] Early evaluation of neoadjuvant chemotherapy response using FDG-PET/CT predicts survival prognosis in patients with head and neck squamous cell carcinoma
    Kikuchi, Masahiro
    Nakamoto, Yuji
    Shinohara, Shogo
    Fujiwara, Keizo
    Yamazaki, Hiroshi
    Kanazawa, Yuji
    Kurihara, Risa
    Kishimoto, Ippei
    Harada, Hiroyuki
    Naito, Yasushi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2013, 18 (03) : 402 - 410